Date published: 2026-5-10

1-800-457-3801

SCBT Portrait Logo
Seach Input

p63 Antibody (E-9): sc-398800

0.0(0)
Write a reviewAsk a question

Datasheets
  • p63 Antibody (E-9) is a mouse monoclonal IgG1 κ provided at 200 µg/ml
  • raised against amino acids 15-151 of ΔN p63α of human origin
  • recommended for detection of all p63 isoforms of human origin by WB, IP, IF and ELISA
  • m-IgG Fc BP-HRP, m-IgG1 BP-HRP and m-IgGκ BP-HRP are the preferred secondary detection reagents for p63 Antibody (E-9) for WB applications. These reagents are now offered in bundles with p63 Antibody (E-9) (see ordering information below).
    Gene Editing Promo Banner

    QUICK LINKS

    SEE ALSO...

    p63 Antibody (E-9) is a mouse monoclonal IgG1 kappa light chain antibody that detects p63 of human origin by western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), and enzyme-linked immunosorbent assay (ELISA). anti-p63 antibody (E-9) is available in non-conjugated form. p63 (E-9) monoclonal antibody recognizes a crucial transcription factor that plays a significant role in epithelial development and stem cell population maintenance. p63 exists as twelve isoforms, primarily categorized into two main variants: TAp63 and ΔNp63, which arise from alternate promoters and undergo extensive alternative splicing. TAp63, which shares a transactivation domain with p53, is essential for processes such as tubulogenesis and cyst formation, while ΔNp63, known for its oncogenic properties, is vital for cell growth and survival, often acting as a dominant-negative regulator over TAp63 and p53. p63′s ability to modulate these critical cellular functions underscores its importance in both normal development and cancer biology, making anti-p63 antibody (E-9) an invaluable tool for researchers studying these pathways.

    For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.

    Alexa Fluor® is a trademark of Molecular Probes Inc., OR., USA

    LI-COR® and Odyssey® are registered trademarks of LI-COR Biosciences

    p63 Antibody (E-9) References:

    1. p63, cellular senescence and tumor development.  |  Guo, X. and Mills, AA. 2007. Cell Cycle. 6: 305-11. PMID: 17224650
    2. p63 in skin appendage development.  |  Mikkola, ML. 2007. Cell Cycle. 6: 285-90. PMID: 17264678
    3. p63 in epithelial development.  |  Candi, E., et al. 2008. Cell Mol Life Sci. 65: 3126-33. PMID: 18560758
    4. p63 is a suppressor of tumorigenesis and metastasis interacting with mutant p53.  |  Melino, G. 2011. Cell Death Differ. 18: 1487-99. PMID: 21760596
    5. p53/p63/p73 in the epidermis in health and disease.  |  Botchkarev, VA. and Flores, ER. 2014. Cold Spring Harb Perspect Med. 4: PMID: 25085956
    6. A double dealing tale of p63: an oncogene or a tumor suppressor.  |  Chen, Y., et al. 2018. Cell Mol Life Sci. 75: 965-973. PMID: 28975366
    7. Master regulatory role of p63 in epidermal development and disease.  |  Soares, E. and Zhou, H. 2018. Cell Mol Life Sci. 75: 1179-1190. PMID: 29103147
    8. Molecular Mechanisms of p63-Mediated Squamous Cancer Pathogenesis.  |  Moses, MA., et al. 2019. Int J Mol Sci. 20: PMID: 31340447
    9. Isoform-Specific Roles of Mutant p63 in Human Diseases.  |  Osterburg, C., et al. 2021. Cancers (Basel). 13: PMID: 33572532
    10. P63 and P73 Activation in Cancers with p53 Mutation.  |  Cai, BH., et al. 2022. Biomedicines. 10: PMID: 35884795

    Ordering Information

    Product NameCatalog #UNITPriceQtyFAVORITES

    p63 Antibody (E-9)

    sc-398800
    200 µg/ml
    $322.00

    p63 Antibody (E-9): m-IgG Fc BP-HRP Bundle

    sc-530935
    200 µg Ab; 10 µg BP
    $361.00

    p63 Antibody (E-9): m-IgGκ BP-HRP Bundle

    sc-524494
    200 µg Ab, 40 µg BP
    $361.00

    p63 Antibody (E-9): m-IgG1 BP-HRP Bundle

    sc-544324
    200 µg Ab; 20 µg BP
    $361.00